Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

NCT02284490 is registered in ClinicalTrials.gov with Rongjie Tao as lead sponsor.

NCT NCT02284490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Lead sponsor
Rongjie Tao
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2014
Completion date
November 30, 2017
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases